Primary information |
---|
CancerPPD ID | 3834 |
PMID | 20515045 |
YEAR | 2010 |
SEQUENCE | IVRRADRAAVP |
LENGTH | 11 |
NAME | ES-2 |
C-ter Modification | Free |
N-ter Modification | Free |
Linear/Cyclic | Linear |
L/D/Mix | L |
Non-Natural | None |
NATURE | Antitumor |
ACTIVITY | 60% inhibition at 2.5µg/ml |
SOURCE | Endostatin derived synthetic peptide |
Cancer Type | Tumor |
ASSAY | MTT/MTS assay |
Patent ID | None |
Tissue | Not Available |
CELL LINE | BAE |
TEST TIME | NA |
Secondary information |
---|
STRUCTURE | |
DSSP states | CCCCCCCSSCC |
SMILES | N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)O |
External Links |
---|
PDB exact | PDB partial | SP exact | SP partial | TrEMBL exact | TrEMBL partial | IEDB exact | IEDB partial |
NA | NA | NA | NA | NA | NA | NA | NA |
|